Intramuscular Diclofenac in the Prevention of Post-ERCP Pancreatitis
NCT01717599
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
343
Enrollment
OTHER
Sponsor class
Conditions
Post ERCP Pancreatitis
Interventions
DRUG:
Diclofenac
DRUG:
normal saline
Sponsor
Yonsei University